TruTrace Technologies Inc (CSE:TTT) (OTCMKTS:TTTSF), the medical cannabis verification company, said Tuesday that it has inked a pact with Anandia Laboratories Inc to collaborate on analytical and genetic testing for cannabis.
In a statement, the company said it plans to establish a strategic working relationship with Anandia to collaborate on an integrated testing solution linked to TruTrace's development of StrainSecure, the first blockchain platform, that registers and tracks cannabis intellectual property.
The Vancouver-based firm’s blockchain-based platform is designed to guarantee product quality and genetics throughout the cannabis supply chain from genome to patient. It combines the power of big data with the security of blockchain to provide strain identification, registration and verification available for cannabis at scale.
Anandia is considered an industry leader in science, genetics, and independent cannabis product testing. Following the agreement, Anandia will serve as a primary analytical and genetic testing partner for TruTrace. The two will also explore ways to rapidly expedite the testing processes to meet Health Canada regulations, as well as evolve genetic testing practices in the cannabis industry.
TruTrace recently announced a milestone deal with Shopper Drug Mart, to see a pilot program use TruTrace's StrainSecure technology as a central hub for identity management, asset tracking, validation, and product authentication. StrainSecure will also serve as a master registry for standardized testing, product verification, and quality assurance.
The company said Anandia will provide testing facilities in the Shoppers Drug Mart and TruTrace Technologies medical cannabis verification pilot program.
"We are very excited to have Anandia join us as a testing partner in the StrainSecure ecosystem," said TruTrace Technologies CEO Robert Galarza in a statement.
"Its genetic testing expertise and capabilities combined with its full range of analytical testing makes it a 'one-stop shop' that we expect will play an important role in our traceability program."
Anandia president and cofounder Dr John Coleman said establishing a comprehensive traceability program is key to providing “full transparency and verification” to medical cannabis patients and consumers.
"We are supportive of these objectives and look forward to working with TruTrace, Shoppers and others in the pilot program," added Coleman.
Contact Uttara Choudhury at [email protected]
Follow her on Twitter: @UttaraProactive